GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prince Pharmaceutical Co Ltd (ROCO:6935) » Definitions » YoY EBITDA Growth

Prince Pharmaceutical Co (ROCO:6935) YoY EBITDA Growth : -79.67% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Prince Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Prince Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -79.67%.

Prince Pharmaceutical Co's EBITDA per Share for the six months ended in Dec. 2024 was NT$0.26.

Prince Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for Prince Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prince Pharmaceutical Co YoY EBITDA Growth Chart

Prince Pharmaceutical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial -146.75 652.74 187.40 -35.75 -76.68

Prince Pharmaceutical Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.58 -46.28 -22.19 -73.32 -79.67

Prince Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Prince Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(0.564-2.419)/ | 2.419 |
=-76.68 %

Prince Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(0.258-1.269)/ | 1.269 |
=-79.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prince Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Prince Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Prince Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prince Pharmaceutical Co Ltd (ROCO:6935) » Definitions » YoY EBITDA Growth
Comparable Companies
ROCO:6483 ROCO:7561 ROCO:6539 ROCO:6677 ROCO:5398 ROCO:6621 ROCO:6496 ROCO:4117 ROCO:4127 ROCO:1780 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Number 168, Keyunnan Road, Huwei Town, Yunlin, TWN, 632
Website
https://www.prince-pharm.com.tw
Prince Pharmaceutical Co Ltd is engaged in the manufacturing, packaging, processing, and trading of various active pharmaceutical ingredients and health supplements. The company supplies its products to Taiwan, Japan, Spain, Europe and other regions.

Prince Pharmaceutical Co Headlines

No Headlines